Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) Trading 0.2% Higher – Time to Buy?

Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) shares were up 0.2% during mid-day trading on Thursday . The stock traded as high as $25.32 and last traded at $25.34. Approximately 449 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 4,849 shares. The stock had previously closed at $25.28.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Stock Performance

The business has a 50-day moving average price of $25.29 and a 200 day moving average price of $25.36.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Wednesday, January 15th were issued a dividend of $0.5391 per share. The ex-dividend date of this dividend was Wednesday, January 15th. This is an increase from Harrow Health, Inc. 8.625% Senior Notes due 2026’s previous quarterly dividend of $0.54. This represents a $2.16 annualized dividend and a yield of 8.53%.

About Harrow Health, Inc. 8.625% Senior Notes due 2026

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.